Topper James N
CIK 1341382
Transactions on file
19
Open-market buys
15
Win rate (buys)
100%
15 scored
Avg % since filing (buys)
+95.2%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 2026-05-19 | PHAT Phathom Pharmaceuticals, Inc. | Grant | 24,122 | $0.00 | — | open → | |
| 2025-03-06 | 2025-03-04 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 4,005 | $84.2K | +32.2% | open → |
| 2025-03-28 | 2025-03-26 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 1,135 | $25.5K | +23.6% | open → |
| 2025-05-13 | 2025-05-09 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 33,376 | $106.5K | +174.3% | open → |
| 2025-05-13 | 2025-05-12 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 12,601 | $38.3K | +187.8% | open → |
| 2025-05-13 | 2025-05-09 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 2,226 | $8.1K | +141.7% | open → |
| 2025-05-15 | 2025-05-14 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 6,300 | $20.9K | +163.6% | open → |
| 2025-05-15 | 2025-05-13 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 1,120 | $3.5K | +176.9% | open → |
| 2025-05-23 | 2025-05-21 | PHAT Phathom Pharmaceuticals, Inc. | Director | Buy | 3,780 | $14.6K | +126.7% | open → |
| 2025-06-05 | 2025-06-03 | PHAT Phathom Pharmaceuticals, Inc. | Director10% | Grant | 10,500 | $0.00 | — | open → |
| 2025-06-18 | 2025-06-16 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 8,584 | $167.4K | +42.5% | open → |
| 2025-06-26 | 2025-06-25 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 1,260 | $23.0K | +52.2% | open → |
| 2025-06-26 | 2025-06-24 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 2,520 | $46.4K | +50.8% | open → |
| 2025-08-13 | 2025-08-11 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 471 | $11.3K | +15.9% | open → |
| 2025-09-10 | 2025-09-08 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 1,260 | $31.5K | +11.2% | open → |
| 2025-09-17 | 2025-09-17 | HLVX HilleVax, Inc. | 10% | U | 17,199 | $33.5K | — | open → |
| 2025-09-17 | 2025-09-17 | HLVX HilleVax, Inc. | 10% | U | 8,535,337 | $16.64M | — | open → |
| 2025-09-17 | 2025-09-15 | NAMS NewAmsterdam Pharma Co N.V. | Director | Buy | 660 | $15.6K | +17.3% | open → |
| 2025-09-30 | 2025-09-26 | MBX MBX Biosciences, Inc. | 10% | Buy | 666,666 | $12.00M | +210.7% | open → |
